Fariba Danesh, Director of Aehr Test Systems, Inc. (AEHR +3.54%), exercised 8,000 stock options and immediately sold the shares on April 16, 2026, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $82.63, coinciding with a significant 890.8% year-over-year stock appreciation, driven in part by a record $41 million order from an AI hyperscale customer.
This transaction highlights Danesh’s liquidity needs, as it involved the exercise of options likely tied to expiring awards rather than a bearish outlook on the stock. Despite the sale, Danesh retains a 0.04% ownership stake in the company, which has seen its stock price soar amid increasing demand for semiconductor testing solutions. However, Aehr’s recent sales figures have not kept pace with its market valuation, raising questions about sustainability as the price-to-sales ratio exceeds 55.
Investors should view Danesh’s transaction as a strategic move rather than a negative signal. With the stock at a high valuation following strong bookings, the current market dynamics suggest it may be wise to exercise caution before initiating new positions in Aehr.
Source: fool.com